Butyrate Metabolism‐Related Gene Signature in Tumor Immune Microenvironment in Lung Adenocarcinoma: A Comprehensive Bioinformatics Study
Jing Zhao, Xueyue Wang, Jing Wang, Yating You, Qi Wang, Yuan Xu, Ye Fan · 2024
Read Butyrate Metabolism‐Related Gene Signature in Tumor Immune Microenvironment in Lung Adenocarcinoma: A Comprehensive Bioinformatics Study by Jing Zhao, Xueyue Wang, Jing Wang, Yating You, Qi Wang, Yuan Xu, Ye Fan (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621860.txt.
Description
Butyrate, a fatty acid made by gut bacteria, can slow tumor growth, yet its role inside lung tumors is little understood. Jing Zhao and co-authors mine a large cancer database for genes tied to butyrate use whose activity differs between lung adenocarcinoma and healthy tissue. They find 38 such genes and build a risk score from nine of them.
Patients with high scores tended to survive for less time, marking the score as a warning sign. One gene, PTGDS, stood out for its links to T cells and the signaling routes they use. The team also found that nine drugs differ in predicted effect between high- and low-risk groups. Their 2024 study frames butyrate metabolism as a promising angle on treating this cancer through the immune system.
Catalog record
| CREATOR | Jing Zhao, Xueyue Wang, Jing Wang, Yating You, Qi Wang, Yuan Xu, Ye Fan |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |